China Universal Asset Management Co., Ltd. Denali Therapeutics Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 30,517 shares of DNLI stock, worth $452,261. This represents 0.06% of its overall portfolio holdings.
Number of Shares
30,517
Previous 27,535
10.83%
Holding current value
$452,261
Previous $802,000
22.57%
% of portfolio
0.06%
Previous 0.09%
Shares
15 transactions
Others Institutions Holding DNLI
# of Institutions
240Shares Held
121MCall Options Held
80KPut Options Held
36.8K-
Black Rock Inc. New York, NY13.2MShares$195 Million0.01% of portfolio
-
Baillie Gifford & CO12.3MShares$182 Million0.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$178 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA9.85MShares$146 Million0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA5.48MShares$81.2 Million0.02% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $1.99B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...